|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-5-7
|
|
pubmed:abstractText |
Total proctocolectomy and ileal pouch anal anastomosis (IPAA) is the preferred operation for patients with chronic ulcerative colitis (CUC) refractory to medical therapy. Infliximab (IFX), an antitumor necrosis factor-alpha antibody, has demonstrated efficacy in medical management of CUC. The aim of this study is to determine if IFX before IPAA impacts short-term outcomes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1072-7515
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
204
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
956-62; discussion 962-3
|
|
pubmed:dateRevised |
2007-11-26
|
|
pubmed:meshHeading |
pubmed-meshheading:17481518-Adult,
pubmed-meshheading:17481518-Antibodies, Monoclonal,
pubmed-meshheading:17481518-Chi-Square Distribution,
pubmed-meshheading:17481518-Chronic Disease,
pubmed-meshheading:17481518-Colitis, Ulcerative,
pubmed-meshheading:17481518-Female,
pubmed-meshheading:17481518-Gastrointestinal Agents,
pubmed-meshheading:17481518-Humans,
pubmed-meshheading:17481518-Logistic Models,
pubmed-meshheading:17481518-Male,
pubmed-meshheading:17481518-Postoperative Complications,
pubmed-meshheading:17481518-Proctocolectomy, Restorative,
pubmed-meshheading:17481518-Retrospective Studies,
pubmed-meshheading:17481518-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.
|
|
pubmed:affiliation |
Division of Colon and Rectal Surgery, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
